⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2989708 | 1.00 | — | — | |
| SCHEMBL57467 | 1.00 | — | — | |
| SCHEMBL9547524 | 0.87 | — | — | |
| SCHEMBL3486434 | 0.87 | — | — | |
| SCHEMBL28862261 | 0.87 | — | — | |
| Bromide SCHEMBL3229526 | 0.87 | — | — | |
| SCHEMBL9771245 | 0.87 | — | — | |
| SCHEMBL3342442 | 0.87 | — | — | |
| SCHEMBL9547532 | 0.87 | — | — | |
| SCHEMBL9787170 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1996188-B1 | BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE | GLAXO GROUP LTD (GB) | 2013-05-15 | — | — | EP | claimed |
| EP-0872248-A2 | Pharmaceutical vehicles for reducing transdermal flux | Access Pharmaceuticals, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| EP-0506207-A2 | Pharmaceutical vehicles for reducing transdermal flux | CHEMEX PHARMACEUTICALS, Inc. (US) | 1992-09-30 | — | — | EP | claimed |
| EP-0294615-B1 | CYCLOBUTENE-3,4-DIONE-INTERMEDIATES AND THEIR USE IN THE PREPARATION OF HISTAMINE H2-ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 1992-04-15 | — | — | EP | claimed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | claimed |
| CN-118056309-A | Flame-retardant nonaqueous electrolyte and secondary battery using same | 国立大学法人京都大学 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023079988-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | 国立大学法人京都大学 | 2023-05-11 | — | — | WO | disclosed |
| CN-108475822-B | Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same | 斯泰拉化工公司 | 2022-03-11 | — | — | CN | disclosed |
| US-11261280-B2 | Fluorinated block copolymers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-03-01 | — | — | US | disclosed |
| US-20210284780-A1 | FLUORINATED BLOCK COPOLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2021-09-16 | — | — | US | disclosed |
| CN-107431245-B | Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same | 斯泰拉化工公司 | 2021-08-10 | — | — | CN | disclosed |
| WO-2018136331-A1 | FLUORINATED BLOCK COPOLYMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-26 | — | — | WO | disclosed |
| EP-0872248-A2 | Pharmaceutical vehicles for reducing transdermal flux | Access Pharmaceuticals, Inc. (US) | 1998-10-21 | — | — | EP | disclosed |
| EP-0506207-A2 | Pharmaceutical vehicles for reducing transdermal flux | CHEMEX PHARMACEUTICALS, Inc. (US) | 1992-09-30 | — | — | EP | disclosed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | disclosed |
| WO-1988003799-A1 | PHARMACEUTICAL VEHICLES FOR REDUCING TRANSDERMAL FLUX | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | disclosed |
| EP-0221176-A4 | PHARMACEUTICAL VEHICLES FOR RECUCING TRANSDERMAL FLUX. | CHEMEX PHARMACEUTICALS INC (US) | 1988-01-25 | — | — | EP | disclosed |
| EP-0221176-A1 | PHARMACEUTICAL VEHICLES FOR RECUCING TRANSDERMAL FLUX. | CHEMEX PHARMACEUTICALS INC (US) | 1987-05-13 | — | — | EP | disclosed |
| WO-1986006586-A1 | PHARMACEUTICAL VEHICLES FOR RECUCING TRANSDERMAL FLUX | CHEMEX PHARMACEUTICALS, INC. (US) | 1986-11-20 | — | — | WO | disclosed |
| US-4002691-A | Polycyclic compounds | ETHYL CORPORATION (US) | 1977-01-11 | — | — | US | disclosed |